INZY
Price
$0.91
Change
+$0.04 (+4.60%)
Updated
Apr 2, 04:17 PM (EDT)
Capitalization
55.89M
41 days until earnings call
MRSN
Price
$0.34
Change
+$0.01 (+3.03%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
42.9M
40 days until earnings call
Ad is loading...

INZY vs MRSN

Header iconINZY vs MRSN Comparison
Open Charts INZY vs MRSNBanner chart's image
Inozyme Pharma
Price$0.91
Change+$0.04 (+4.60%)
Volume$100
Capitalization55.89M
Mersana Therapeutics
Price$0.34
Change+$0.01 (+3.03%)
Volume$58.4K
Capitalization42.9M
INZY vs MRSN Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INZY vs. MRSN commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Hold and MRSN is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (INZY: $0.87 vs. MRSN: $0.33)
Brand notoriety: INZY and MRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 77% vs. MRSN: 91%
Market capitalization -- INZY: $55.89M vs. MRSN: $42.9M
INZY [@Biotechnology] is valued at $55.89M. MRSN’s [@Biotechnology] market capitalization is $42.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 1 FA rating(s) are green whileMRSN’s FA Score has 0 green FA rating(s).

  • INZY’s FA Score: 1 green, 4 red.
  • MRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, INZY is a better buy in the long-term than MRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 4 TA indicator(s) are bullish while MRSN’s TA Score has 4 bullish TA indicator(s).

  • INZY’s TA Score: 4 bullish, 2 bearish.
  • MRSN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, INZY is a better buy in the short-term than MRSN.

Price Growth

INZY (@Biotechnology) experienced а -10.41% price change this week, while MRSN (@Biotechnology) price change was -25.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.95%. For the same industry, the average monthly price growth was -7.12%, and the average quarterly price growth was -11.69%.

Reported Earning Dates

INZY is expected to report earnings on May 13, 2025.

MRSN is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-4.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INZY($55.9M) has a higher market cap than MRSN($42.9M). INZY YTD gains are higher at: -68.592 vs. MRSN (-76.622). MRSN has higher annual earnings (EBITDA): -63.27M vs. INZY (-95.72M). MRSN has more cash in the bank: 135M vs. INZY (113M). MRSN has less debt than INZY: MRSN (28.6M) vs INZY (46.9M). MRSN has higher revenues than INZY: MRSN (40.5M) vs INZY (0).
INZYMRSNINZY / MRSN
Capitalization55.9M42.9M130%
EBITDA-95.72M-63.27M151%
Gain YTD-68.592-76.62290%
P/E RatioN/AN/A-
Revenue040.5M-
Total Cash113M135M84%
Total Debt46.9M28.6M164%
FUNDAMENTALS RATINGS
MRSN: Fundamental Ratings
MRSN
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INZYMRSN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
86%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LVWR2.090.09
+4.50%
LiveWire Group
ECL254.270.75
+0.30%
Ecolab
ADC76.84-0.35
-0.45%
Agree Realty Corp
RPID2.61-0.03
-1.14%
Rapid Micro Biosystems
MRVI2.16-0.05
-2.26%
Maravai LifeSciences Holdings

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with IGMS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-4.40%
IGMS - INZY
52%
Loosely correlated
N/A
MRSN - INZY
50%
Loosely correlated
-2.88%
CRNX - INZY
48%
Loosely correlated
-8.71%
DYN - INZY
48%
Loosely correlated
-11.76%
APGE - INZY
46%
Loosely correlated
-4.68%
More

MRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRSN has been loosely correlated with IGMS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if MRSN jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRSN
1D Price
Change %
MRSN100%
-2.88%
IGMS - MRSN
53%
Loosely correlated
N/A
INZY - MRSN
50%
Loosely correlated
-4.40%
DYN - MRSN
46%
Loosely correlated
-11.76%
CRNX - MRSN
44%
Loosely correlated
-8.71%
RGNX - MRSN
42%
Loosely correlated
-5.45%
More